as on November 27, 2025 at 2:29 am IST
Day's Low
Day's High
9.91%
Downside
0.90%
Upside
52 Week's Low
52 Week's High
18.02%
Downside
345.04%
Upside
Check Tscan Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$55.5M
EPS (TTM)
-1.244
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-2.63
Industry PE ratio
0PEG Ratio
0EBITDA
-145.8M
Revenue (TTM)
8.4M
Profit Margin
0.00%
Return On Equity TTM
-76.44%
Track how Tscan Therapeutics Inc P/E has moved over time to understand its valuation trends.
Tscan Therapeutics Inc in the last 5 years
Lowest (-7.50x)
June 30, 2024
Industry (0.00x)
November 27, 2025
Today (-2.63x)
November 27, 2025
Highest (-0.45x)
March 31, 2022
Today’s Price to Earnings Ratio: -2.63x
Compare market cap, revenue, PE, and other key metrics of Tscan Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $55.5M | NA | -2.63 | 0.00% | |
| BUY | $43.6B | 413.84% | -16.34 | -264.83% | |
| BUY | $56.8B | 242.77% | 1432.67 | 1.36% | |
| BUY | $110.2B | 90.63% | 30.21 | 31.35% | |
| BUY | $83.4B | 52.63% | 18.87 | 32.13% |
The Tscan Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Tscan Therapeutics Inc investment value today
Current value as on today
₹29,063
Returns
Returns from Tscan Therapeutics Inc Stock
Dollar Returns*
₹5,792 (+5.79%)
Based on 12 analysts
91.67%
Buy
8.33%
Hold
0.00%
Sell
Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Tscan Therapeutics Inc. Average target price of $5.75
Get share price movements and forecasts by analysts on Tscan Therapeutics Inc.
What analysts predicted
80.7%UPSIDE
Target Price
$5.75
Current Price
$1.11
Analyzed by
12 Analysts
Target
$5.75
Tscan Therapeutics Inc target price $5.75, a slight upside of 80.7% compared to current price of $1.11. According to 12 analysts rating.
Search interest for Tscan Therapeutics Inc Stock has increased by 163% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:163% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -36.95M → -35.71M (in $), with an average increase of 3.5% per quarter
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 1010.9% return, outperforming this stock by 1063.7%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 169.5% return, outperforming this stock by 246.2%
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 3.07M → 2.51M (in $), with an average decrease of 18.4% per quarter
Price Dip
![]()
In the last 1 month, TCRX stock has moved down by -51.3%
| Organisation | Tscan Therapeutics Inc |
| Headquarters | 830 Winter Street, Waltham, MA, United States, 02451 |
| CEO | Dr. Gavin MacBeath Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Chrystal U. Louis M.D., M.P.H. | Chief Medical Officer |
Dr. Stephen J. Elledge Ph.D. | Co-Founder & Chairman of Scientific Advisory Board |
Mr. Leiden Dworak M.B.A. | Principal Accounting Officer |
Dr. Zoran Zdraveski J.D., Ph.D. | Chief Legal & Strategy Officer and Company Secretary |
Mr. Ray Lockard M.B.A. | Senior Vice President & Head of Quality |
Dr. Gavin MacBeath Ph.D. | CEO & Director |
Mr. Jason A. Amello CPA | CFO & Treasurer |
Mr. Tomasz Kula Ph.D. | Co-Founder & Member of Advisory Board |
Ms. Ann Hargraves | Senior Vice President of Human Resources |
Dr. Shrikanta Chattopadhyay M.D. | Senior VP & Head of Translational Medicine |
Tscan Therapeutics Inc share price today is $1.11 as on at the close of the market. Tscan Therapeutics Inc share today touched a day high of $1.12 and a low of $1.
Tscan Therapeutics Inc share touched a 52 week high of $4.94 on and a 52 week low of $0.91 on . Tscan Therapeutics Inc stock price today i.e. is closed at $1.11,which is 77.53% down from its 52 week high and 21.98% up from its 52 week low.
Tscan Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Tscan Therapeutics Inc (TCRX) shares with as little as ₹89.31 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹893.10 in Tscan Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Tscan Therapeutics Inc share’s latest price of $1.11 as on November 27, 2025 at 2:29 am IST, you will get 9.0090 shares of Tscan Therapeutics Inc. Learn more about
fractional shares .